跳至主要内容
临床试验/ISRCTN61164781
ISRCTN61164781进行中(未招募)未知

A novel approach to clinical practice by using a shared decision-making model to target cardiovascular risk: The YANKEES (Your demographics, Adherence, Nutrition, Knowledge, Environment, E-EtOH [alcohol], Smoking, Sleep-quality) study

ew York State Department of Health0 个研究点目标入组 600 人开始时间: 2019年10月14日最近更新:
适应症

试验速览

阶段
未知
状态
进行中(未招募)
发起方
入组人数
600

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Ambulatory clinic patients that have an established record with a history of two appointments and follow-ups
  • 2. Age 18 years and above
  • 3. Hypertension, medical diagnosis with no more than three anti-hypertensive medications
  • 4. Medical diagnosis of Diabetes Mellitus with hemoglobin A1c less than or equal to 8.0%
  • 5. Calculated Body Mass Index between 25 kg/m2 and 40 kg/m2

排除标准

  • 1. Unable to provide informed consent in either English or Spanish for any reason, including cognitive impairment, psychiatric illness, drug or alcohol intoxication
  • 2. Pregnant or are planning to become pregnant within the year
  • 3. Participating in other trials, e.g. weight loss study
  • 4. Prior history or present medical condition and/or surgical procedure related to the primary gastrointestinal tracts and/or accessory digestive organs affecting the transit or absorption of ingested nutrients, including but not limited to bariatric, pancreatic disease and multiple bowel surgeries
  • 5. Severe comorbid diseases that can lead to unintentional weight change including cancer, HIV/AIDS, autoimmune disease, including and not limited to inflammatory bowel disease, in addition to chronic kidney disease, chronic liver disease and chronic heart disease
  • 6. Severe disease, a terminal illness, be incapacitated (including stroke, myocardial infarction, coronary artery disease) with an expected limited life-span of less than a year
  • 7. Living in an institutional setting (including nursing home, prison or group home)
  • 8. Lab value abnormalities that preclude from participation in study interventions (i.e. significant anemia; derangement in electrolytes; elevation in liver function test; etc.) determined by the Investigator
  • 9. Abnormalities in electrocardiogram studies, unless reviewed and cleared by a physician

研究者

发起方
ew York State Department of Health

相似试验